CHST9 antibody (AA 33-129) (FITC)

Catalog No. ABIN7146694

This anti-CHST9 antibody is a Rabbit Polyclonal antibody detecting CHST9 in not_set. Suitable for Human.

Quick Overview for CHST9 antibody (AA 33-129) (FITC) (ABIN7146694)

Target: CHST9 (Carbohydrate (N-Acetylgalactosamine 4-0) Sulfotransferase 9 (CHST9))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CHST9 antibody is conjugated to FITC

Application: Please inquire

Product Details anti-CHST9 Antibody (FITC)

Binding Specificity: AA 33-129

Purpose: CHST9 Antibody, FITC conjugated

Purification: Protein G purified

Purity: >95 %

Immunogen: Recombinant Human Carbohydrate sulfotransferase 9 protein (33-129AA)

Isotype: IgG

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for CHST9

Target: CHST9 (Carbohydrate (N-Acetylgalactosamine 4-0) Sulfotransferase 9 (CHST9))

Alternative Name: CHST9

Background:

Background: Catalyzes the transfer of sulfate to position 4 of non-reducing N-acetylgalactosamine (GalNAc) residues in both N-glycans and O-glycans. Participates in biosynthesis of glycoprotein hormones lutropin and thyrotropin, by mediating sulfation of their carbohydrate structures. Has a higher activity toward carbonic anhydrase VI than toward lutropin. Only active against terminal GalNAcbeta1,GalNAcbeta. Isoform 2, but not isoform 1, is active toward chondroitin.

Aliases: Carbohydrate sulfotransferase 9 antibody, Chst9 antibody, CHST9_HUMAN antibody, GalNAc-4-O-sulfotransferase 2 antibody, GalNAc-4-ST2 antibody, GalNAc4ST-2 antibody, N-acetylgalactosamine-4-O-sulfotransferase 2 antibody, UNQ2549/PRO6175 antibody

UniProt: Q7L1S5

Pathways: Glycosaminoglycan Metabolic Process